AA
CPIX icon

Ancora Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History

Ancora Advisors’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,600
Closed -$20K – 692
2016
Q4 		$20K Buy
+3,600
New +$18.8K ﹤0.01% 930

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ancora Advisors's CPIX Position: Q1 2017 in Review

Ancora Advisors sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2017, closing a stake of 3,600 shares — an estimated $20K sold.

Ancora Advisors first reported a position in CPIX in Q4 2016 and held it in 1 quarter. The position peaked at $20K in Q4 2016. 36 funds tracked by Wall St. Rank hold CPIX as of Q1 2017.

  • Ancora Advisors reported no remaining Cumberland Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Ancora Advisors sold 3,600 Cumberland Pharmaceuticals shares in Q1 2017, an estimated $20K.
  • Ancora Advisors first reported a position in Cumberland Pharmaceuticals in Q4 2016 and held it in 1 quarter.
  • Ancora Advisors's Cumberland Pharmaceuticals position peaked at $20K in Q4 2016.
  • 36 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2017.

Based on Ancora Advisors's 13F filing for Q1 2017, filed 15 May 2017.